Foresite Capital Management Iv, LLC Replimune Group, Inc. Transaction History

Foresite Capital Management Iv, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$10.01 - $16.87 $12.3 Million - $20.7 Million	-1,228,656 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$12.51 - $17.28 $12,510 - $17,280	-1,000 Reduced 0.08%	1,228,656 $18 Million
Q3 2018 Nov 13, 2018	BUY	$14.99 - $22.14 $18.4 Million - $27.2 Million	1,229,656 New	1,229,656 $19.8 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $693M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.